Synthesis of transition-metal adamantane salts and oxide nanocomposites, and systems and methods including the salts or the nanocomposites
US-10105684-B2 · Oct 23, 2018 · US
US10906859B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10906859-B2 |
| Application number | US-201816157542-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 11, 2018 |
| Priority date | Mar 17, 2016 |
| Publication date | Feb 2, 2021 |
| Grant date | Feb 2, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Embodiments are directed to adamantane-intercalated layered double-hydroxide (LDH) particles and the methods of producing adamantane-intercalated LDH particles. The adamantane-intercalated LDH particles have a general formula defined by [M1-xAlx(OH)2](A)x.mH2O, where x is from 0.14 to 0.33, m is from 0.33 to 0.50, M is chosen from Mg, Ca, Co, Ni, Cu, or Zn, and A is adamantane carboxylate. The adamantane-intercalated LDH particles further have an aspect ratio greater than 100. The aspect ratio is defined by the width of an adamantane-intercalated LDH particle divided by the thickness of the adamantane-intercalated LDH particle.
Opening claim text (preview).
What is claimed is: 1. An adamantane-intercalated layered double-hydroxide (LDH) material in a form of adamantane-intercalated LDH particles, where the adamantane-intercalated LDH particles comprise: a general formula defined by [M 1-x Al x (OH) 2 ](A) x .mH 2 O, where x is from 0.14 to 0.33, m is from 0.33 to 0.50, M is chosen from Mg, Ca, Co, Ni, Cu, or Zn, and A is adamantane carboxylate; and an aspect ratio greater than 100, the aspect ratio defined by a width of an adamantane-intercalated LDH particle divided by a thickness of the adamantane-intercalated LDH particle. 2. The adamantane-intercalated LDH material of claim 1 where M is Mg. 3. The adamantane-intercalated LDH material of claim 1 where the aspect ratio is greater than 125. 4. The adamantane-intercalated LDH material of claim 1 where the aspect ratio is greater than 150. 5. The adamantane-intercalated LDH material of claim 1 where the aspect ratio is greater than 200. 6. The adamantane-intercalated LDH material of claim 1 where the adamantane-intercalated LDH particles have a particle diameter of 5 to 10 μm. 7. The adamantane-intercalated LDH material of claim 1 where the adamantane-intercalated LDH particles have characteristic peaks in an IR spectra at 1517 cm −1 , 1395 cm −1 , 2901 cm −1 , 2847 cm −1 , and 4302 cm −1 .
Nuclear magnetic resonance [NMR] · CPC title
Indexing scheme associated with group B01J35/00, related to the analysis techniques used to determine the catalysts form or properties · CPC title
Scanning electron microscopy; Transmission electron microscopy · CPC title
Compounds characterised by their crystallite size · CPC title
Infrared [IR] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.